Clinical trial
Adjuvant Chemo-RT With Cisplatin (NSC-119875) and Docetaxel (NSC-628503) After Complete Resection of Locally Advanced (Stage III and IV) Squamous Cell Carcinoma of the Head and Neck (SCCHN)
NCT00084435 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjuvant Chemo-RT With Cisplatin (NSC-119875) and Docetaxel (NSC-628503) After Complete Resection of Locally Advanced (Stage III and IV) Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Lead sponsor
- SWOG Cancer Research Network
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- July 31, 2005
- Completion date
- January 31, 2007
- Enrollment
- 0 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer